19.10.2016 - The $2 billion initial public offering launched last week in Hong Kong by Chinese state-backed China Resources Pharmaceutical, the country’s second-largest drugmaker, attracted...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)